![](https://webarchive.library.unt.edu/web/20081010121011im_/http://www.nci.nih.gov/images/spacer.gif) |
¿Preguntas sobre el cáncer?
![](https://webarchive.library.unt.edu/web/20081010121011im_/http://www.nci.nih.gov/images/spacer.gif)
|
1-800-422-6237
(1-800-4-CANCER)
|
![](https://webarchive.library.unt.edu/web/20081010121011im_/http://www.nci.nih.gov/images/spacer.gif)
|
Llame de lunes a viernes de 9:00 a.m. a 4:30 p.m., hora local en Estados Unidos y sus territorios. |
|
![](https://webarchive.library.unt.edu/web/20081010121011im_/http://www.nci.nih.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/web/20081010121011im_/http://www.nci.nih.gov/images/spacer.gif)
![](https://webarchive.library.unt.edu/web/20081010121011im_/http://www.nci.nih.gov/images/spacer.gif)
| Sustancia en estudio para el tratamiento de cáncer. Puede destruir células cancerosas al impedir la producción de una proteína que las hace vivir durante más tiempo y al hacerlas más sensibles a los medicamentos contra el cáncer. Es un tipo de oligodesoxirribonucleótido no codificante. También se llama oblimersen, Genasense y bcl-2 oligodesoxinucleótido no codificante G3139. |
![](https://webarchive.library.unt.edu/web/20081010121011im_/http://www.nci.nih.gov/images/spacer.gif)
![](https://webarchive.library.unt.edu/web/20081010121011im_/http://www.nci.nih.gov/images/gray_spacer.gif)
![](https://webarchive.library.unt.edu/web/20081010121011im_/http://www.nci.nih.gov/images/spacer.gif)
|
![](https://webarchive.library.unt.edu/web/20081010121011im_/http://www.nci.nih.gov/images/spacer.gif) |